杜氏肌营养不良症患者在生命第二个十年期间的左心室功能及对依那普利的反应 - Suppr | 超能文献

Left ventricular function and response to enalapril in patients with Duchenne muscular dystrophy during the second decade of life.

作者信息

Giglio Vincenzo

出版信息

Am J Cardiol. 2007 Jan 1;99(1):147-8. doi: 10.1016/j.amjcard.2006.10.008. Epub 2006 Nov 29.

DOI:10.1016/j.amjcard.2006.10.008

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Left ventricular function and response to enalapril in patients with Duchenne muscular dystrophy during the second decade of life.杜氏肌营养不良症患者在生命第二个十年期间的左心室功能及对依那普利的反应

Am J Cardiol. 2007 Jan 1;99(1):147-8. doi: 10.1016/j.amjcard.2006.10.008. Epub 2006 Nov 29.

2

Left ventricular function and response to enalapril in patients with duchenne muscular dystrophy during the second decade of life.杜氏肌营养不良症患者在生命第二个十年期间的左心室功能及对依那普利的反应

Am J Cardiol. 2006 Sep 15;98(6):825-7. doi: 10.1016/j.amjcard.2006.04.020. Epub 2006 Aug 2.

3

Did they lower stress in the trial? Or was it just wasted energy?在试验中它们降低压力了吗？还是只是白费力气？

J Am Coll Cardiol. 2005 Mar 15;45(6):858-9. doi: 10.1016/j.jacc.2004.12.023.

4

Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy.培哚普利对杜氏肌营养不良症左心室功能障碍发生及进展的影响。

J Am Coll Cardiol. 2005 Mar 15;45(6):855-7. doi: 10.1016/j.jacc.2004.09.078.

5

Recovery of systolic dysfunction in duchenne muscular dystrophy due to the point mutation c.4213C>T.由于c.4213C>T点突变导致的杜氏肌营养不良症收缩功能障碍的恢复。

Cardiology. 2010;117(4):265-7. doi: 10.1159/000323515. Epub 2011 Jan 26.

6

Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial.依那普利（ACE 抑制剂）和美托洛尔（β 受体阻滞剂）治疗对杜氏肌营养不良症左心室功能障碍发生的影响和安全性：一项随机、双盲、安慰剂对照试验。

Orphanet J Rare Dis. 2019 May 10;14(1):105. doi: 10.1186/s13023-019-1066-9.

7

Early versus delayed enalapril in patients with left ventricular systolic dysfunction: impact on morbidity and mortality 15 years after the SOLVD trial.左心室收缩功能障碍患者早期与延迟使用依那普利：SOLVD试验15年后对发病率和死亡率的影响

J Am Coll Cardiol. 2006 May 2;47(9):1904-5. doi: 10.1016/j.jacc.2006.02.008. Epub 2006 Apr 17.

8

Missing explanation on enalapril monotherapy.

Am J Hypertens. 1997 Mar;10(3):366.

9

Progressive left ventricular dysfunction and myocardial fibrosis in Duchenne and Becker muscular dystrophy: a longitudinal cardiovascular magnetic resonance study.杜兴氏和贝克氏肌营养不良症患者的进行性左心室功能障碍和心肌纤维化：一项纵向心血管磁共振研究。

Pediatr Cardiol. 2019 Feb;40(2):384-392. doi: 10.1007/s00246-018-2046-x. Epub 2018 Dec 18.

10

[Perspectives for enalapril in the therapy of coronary heart disease. European Cardiology Symposium, Montreux, February 1997].

Dtsch Med Wochenschr. 1997;122(21 Suppl Perspektiv):1-8.

引用本文的文献

1

Progressive left ventricular dysfunction and long-term outcomes in patients with Duchenne muscular dystrophy receiving cardiopulmonary therapies.接受心肺治疗的杜氏肌营养不良症患者的进行性左心室功能障碍及长期预后

Open Heart. 2018 Mar 3;5(1):e000783. doi: 10.1136/openhrt-2018-000783. eCollection 2018.

2

The effect of enalapril and carvedilol on left ventricular dysfunction in middle childhood and adolescent patients with muscular dystrophy.依那普利和卡维地洛对中童年和青少年肌营养不良患者左心室功能障碍的影响。

Korean Circ J. 2012 Mar;42(3):184-91. doi: 10.4070/kcj.2012.42.3.184. Epub 2012 Mar 26.